GCTK
Glucotrack, Inc.Company with tickers: GCTK
CIK
1506983
CUSIP
45824Q804
Shares Outstanding
6,259,279
Website
https://www.glucotrack.com/
13F Activity (30d)
2 filings
1 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $4,203,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $2,132,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-4,203,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-4,334,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $2.65 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $2.65 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |